Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited)

v3.19.3.a.u2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)
Preferred Stock [Member]
Series A Preferred Stock [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Preferred Stock [Member]
Series C Preferred Stock [Member]
Preferred Stock [Member]
Series D Preferred Stock [Member]
Preferred Stock [Member]
Series E Preferred Stock [Member]
Common Stock [Member]
Additional paid-in capital [Member]
Subscription Receivable [Member]
Accumulated deficit [Member]
Total
Balance at Sep. 30, 2018 $ 5 $ 45 $ 7 $ 30 $ 2,039 $ 14,854,301 $ (16,044,512) $ (1,188,085)
Balance, shares at Sep. 30, 2018 512,996 4,433,375 670,904 3,000,000 203,899,190        
Common Stock issued for cash $ 33 99,967 (25,000)   75,000
Common Stock issued for cash, shares 3,333,334        
Net loss (111,160) (111,160)
Balance at Dec. 31, 2018 $ 5 $ 45 $ 7 $ 30 $ 2,072 14,954,268 $ (25,000) (16,155,672) (1,224,245)
Balance, shares at Dec. 31, 2018 512,996 4,433,375 670,904 3,000,000 207,232,524        
Balance at Sep. 30, 2019 $ 5 $ 45 $ 7 $ 30 $ 2,120 15,041,522   (16,221,110) (1,177,381)
Balance, shares at Sep. 30, 2019 512,996 4,433,375 670,904 3,000,000 211,994,635        
Net loss   (37,184) (37,184)
Acquisition of ReadyMed platform in exchange for common shares $ 120 599,880   600,000
Acquisition of ReadyMed platform in exchange for common shares, shares 12,000,000        
Balance at Dec. 31, 2019 $ 5 $ 45 $ 7 $ 30 $ 2,240 $ 15,641,402   $ (16,258,294) $ (614,565)
Balance, shares at Dec. 31, 2019 512,996 4,433,375 670,904 3,000,000 223,994,635